Evidence map›Paper›PMID 41824326›Full record

ArticleJournal of medical microbiology2026

Investigation of carbapenem-hydrolysing

Hiroshi Teraguchi, Ayaka Oda, Satoyo Wakai, Sayoko Kawakami, Koki Yoshida, Wataru Hayashi, Norikazu Kitamura, Yo Sugawara, Naoya Ohara, Motoyuki Sugai and 2 more

Abstract read
In one paragraph

Article in Journal of medical microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Hiroshi TeraguchiDepartment of Clinical Laboratory, Kindai University Nara Hospital, Nara 630-0293, Japan.
Ayaka OdaDental School, Okayama University, Okayama 700-8558, Japan.
Satoyo WakaiAntimicrobial Resistance Research Center, National Institute of Infectious Diseases, Japan Institute for Health Security, Tokyo 189-0002, Japan.
Sayoko KawakamiAntimicrobial Resistance Research Center, National Institute of Infectious Diseases, Japan Institute for Health Security, Tokyo 189-0002, Japan.
Koki YoshidaDepartment of Clinical Laboratory, Kindai University Nara Hospital, Nara 630-0293, Japan.
Wataru HayashiAntimicrobial Resistance Research Center, National Institute of Infectious Diseases, Japan Institute for Health Security, Tokyo 189-0002, Japan.
Norikazu KitamuraAntimicrobial Resistance Research Center, National Institute of Infectious Diseases, Japan Institute for Health Security, Tokyo 189-0002, Japan.
Yo SugawaraAntimicrobial Resistance Research Center, National Institute of Infectious Diseases, Japan Institute for Health Security, Tokyo 189-0002, Japan.
Naoya OharaDental School, Okayama University, Okayama 700-8558, Japan.
Motoyuki SugaiAntimicrobial Resistance Research Center, National Institute of Infectious Diseases, Japan Institute for Health Security, Tokyo 189-0002, Japan.
Koji YaharaAntimicrobial Resistance Research Center, National Institute of Infectious Diseases, Japan Institute for Health Security, Tokyo 189-0002, Japan.
Aki HirabayashiAntimicrobial Resistance Research Center, National Institute of Infectious Diseases, Japan Institute for Health Security, Tokyo 189-0002, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anti-Bacterial AgentsBacterial Proteinsbeta-LactamasesCarbapenemsKlebsiella oxytocaClavulanic AcidHumansHydrolysisKlebsiella InfectionsMicrobial Sensitivity TestsWhole Genome SequencingAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasescarbapenemaseCarbapenemsClavulanic AcidblaOXY-2clavulanic acidKlebsiella oxytocaMICmodified carbapenem inactivation method

Identifiers

PMID41824326
PMCPMC12999891

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.